Compare Aurora Cannabis Inc (ACB) vs iShares Silver Trust (SLV) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

SLV, the iShares Silver Trust ETF, trades at $54.46, down 1.02% on the day, reflecting ongoing volatility in silver prices. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators are neutral. Recent news highlights silver's 50% decline from January peaks but potential for a rebound amid industrial demand and inflation hedging. Financial ratios are not applicable as this is a commodity ETF tracking physical silver.

The outlook for SLV hinges on silver's dual role as an industrial metal and inflation hedge, with risks including Federal Reserve policy shifts and geopolitical tensions. Analysts see potential for price recovery if macroeconomic conditions support precious metals, but near-term volatility remains high due to rate hike expectations and dollar strength.